New PBS listings for cancer indications
Small cell and non-small cell lung cancer and melanoma indications
![](https://www.ausdoc.com.au/wp-content/uploads/2022/08/intravenous_infusion_iv_istock-1069859094-8.jpg)
Two new treatments have been listed on the PBS for lung cancer and melanoma indications, expanded for nivolumab from 1 March.
Durvalumab (Astra Zeneca, Imfinzi) will be listed on the PBS for the first time as a therapy for patients with non-small cell lung cancer who have not progressed after chemoradiation.